Molecular features of prostate cancer post-neoadjuvant therapy in the Phase 3 CALGB 90203 trial. Sumiyoshi T, Wang X, Warner EW, Sboner A, et al. J Natl Cancer Inst 2023 Sep 7:djad184. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Sumiyoshi T, Wang X, Warner EW, Sboner A, et al. Molecular features of prostate cancer post-neoadjuvant therapy in the Phase 3 CALGB 90203 trial. J Natl Cancer Inst 2023 Sep 7:djad184. doi: 10.1093.
PMID: 37676819